Development of Manual Sample Clauses

Development of Manual. The Contractor shall develop and continuously update a detailed, DSHS- specific process and procedures manual that minimally includes the contents specified in this Section (“Process and Procedures Manual”). The existing Process and Procedures manual shall be provided to the Contractor by the previous Maintenance and Operations vendor during the transition-in phase. Contractor will review and update as required. The Contractor will make DSHS aware of the required changes and shall deliver the first draft of the Process and Procedures Manual to DSHS for its review, comments and approval within the reasonable time frame (taking into account the extent of the needed changes) set forth by DSHS and shall, with respect to each draft of the Process and Procedures Manual, incorporate all comments and suggestions from DSHS. Not later than one hundred and twenty (120) calendar days following the effective date, the Contractor shall deliver an updated draft of the Process and Procedures Manual to DSHS for its review, comments and approval and thereafter shall quarterly update the Process and Procedures Manual to reflect changes in the operations or procedures described therein. All such updates to the Process and Procedures Manual shall be provided to DSHS for its prior review, comments and approval. Prior to completion of the Process and Procedures Manual, the Contractor shall, as applicable, provide the Services in accordance with the previously existing ACES Documentation and standards and procedures generally used by DSHS. The Contractor acknowledges that failure to maintain and update the Process and Procedures Manual may constitute a material breach of this Agreement.
AutoNDA by SimpleDocs
Development of Manual. (a) For the purposes of Regional Processing Countries Health Services, the Health Services Manager will use the existing draft Policy and Procedures Manual in accordance with this clause 3, until such time as the final Policy and Procedures Manual has been completed. The final Policy and Procedures Manual must:
Development of Manual. As ACS transitions and migrates Services in accordance with the terms of the Transition Plan, ACS shall develop and continuously update a detailed, Symetra-specific standards and procedures manual that minimally includes the contents specified in Section 2.6.2 (the “Standards and Procedures Manual”). ACS shall deliver the first draft of the Standards and Procedures Manual to Symetra for its review, comments and approval within ninety (90) calendar days following the Effective Date of the Agreement and shall, with respect to each draft of the Standards and Procedures Manual, incorporate all of Symetra’s comments and suggestions. Not later than thirty (30) calendar days following completion of all activities under the Transition Plan, ACS shall deliver an updated draft of the Standards and Procedures Manual to
Development of Manual. On or before December 1, 2009, ACS shall prepare and deliver to Symetra for its review and comments (which comments shall be provided to ACS on or before February 1, 2010) a detailed, Symetra-specific service delivery manual that includes the contents specified in Section 2.6.2 (as updated from time to time, the “Service Delivery Reference Manual”) and shall, with respect to such draft, incorporate all of Symetra’s comments and requested changes. Once the draft Service Delivery Reference Manual has been approved in writing by Symetra (such approved not to be unreasonably withheld, delayed or conditioned), on each of April 1 and October 1 of each Contract Year (excluding October 1, 2009), ACS shall provide to Symetra for its review and comments an updated draft of the Service Delivery Reference Manual that includes: (a) all changes to the contents thereof through such date; and (b) Symetra’s comments and requested changes from the prior draft. ACS’ delivery to Symetra of the Service Delivery Reference Manual and updated drafts of the Service Delivery Reference Manual as provided herein shall constitute Critical Milestones and are subject to Corrective Assessments as provided in Section 3.2 of Schedule 5.
Development of Manual. As specified in the Transition Plan, Contractor shall deliver a reasonable and appropriate draft Standards and Procedures Manual to the County for its review, comment, and approval. At a minimum, the Standards and Procedures Manual should address the topics listed in Schedule 7.3.1. Contractor shall incorporate all comments or suggestions of the County and shall finalize the Standards and Procedures Manual by the dates specified in the Transition Plan. Contractor shall periodically (but not less than monthly) update the Standards and Procedures Manual to reflect changes in the operations or procedures described therein. Updates of the Standards and Procedures Manual shall be provided and delivered at no cost to the County for review and approval. For purposes of clarity, Contractor shall immediately update the Standards and Procedures Manual when changes are necessary, and shall provide those changes to the County in the periodic update required by this Section 7.3.1.
Development of Manual. As ACS transitions and migrates Services in accordance with the terms of the Transition Plan, ACS shall develop and continuously update a detailed, Symetra-specific standards and procedures manual that minimally includes the contents specified in Section 2.6.2 (the “Standards and Procedures Manual”). ACS shall deliver the first draft of the Standards and Procedures Manual to Symetra for its review, comments and approval within ninety (90) calendar days following the Effective Date of the Agreement and shall, with respect to each draft of the Standards and Procedures Manual, incorporate all of Symetra’s comments and suggestions. Not later than thirty (30) calendar days following completion of all activities under the Transition Plan, ACS shall deliver an updated draft of the Standards and Procedures Manual to Symetra for its review, comments and approval and thereafter shall periodically (but not less often than quarterly) update the Standards and Procedures Manual to reflect changes in the operations or procedures described therein. All such updates to the Standards and Procedures Manual shall be provided to Symetra for its prior review, comments and approval. Delivery of the initial draft and the updated draft of the Standards and Procedures Manual as provided herein shall constitute Critical Milestones. Prior to completion of the Standards and Procedures Manual, ACS shall provide the Services in accordance with the standards and procedures generally used by Symetra.
Development of Manual. As part of the Services, and at no additional cost to Client, Supplier shall deliver to Client within the time periods specified in the applicable Services Agreement, for its review, comment and approval (1) an outline of the topics to be addressed in the Policy and Procedures Manual, and (2) an initial draft of the Policy and Procedures Manual (the “Policy and Procedures Manual”). Client shall provide reasonable cooperation to Supplier in connection with Supplier’s preparation of the Policy and Procedures Manual. At a minimum, the Policy and Procedures Manual shall include the following:
AutoNDA by SimpleDocs
Development of Manual. 1.7.2 Content of Manual 1.8 SERVICE COMPATIBILITY
Development of Manual. Within ninety (90) calendar days after the Contract Effective Date, Provider shall deliver a reasonable and appropriate draft standards and procedures manual, specific to the Services to be provided under the Agreement, (“Standards and Procedures Manual”) to Investors for its review, comment, and approval. Provider shall incorporate all relevant comments or suggestions of Investors and shall finalize the Standards and Procedures Manual within one hundred eighty (180) calendar days after the Contract Effective Date. Provider shall periodically (but not less than quarterly) update the Standards and Procedures Manual to reflect changes in the operations or procedures described therein. Updates of the Standards and Procedures Manual shall be provided to Investors for review and approval. To the extent that an Investors requested change to the Standards and Procedures Manual (including proposed changes to the draft version) may materially interfere with or materially degrade Provider’s provision of the Services or have a materially detrimental impact on Provider’s cost of providing the Services or time for delivery of the Services, the Parties shall mutually agree to any requested change pursuant to the change management procedure to be mutually agreed pursuant to Section 7.4 of this Agreement, prior to adopting such change(s).

Related to Development of Manual

  • Development of Products (a) During the term of this Agreement, ViewRay may from time to time seek services from PEKO with respect to the development of certain Products that can be incorporated into the ViewRay Renaissance™ MRI-guided radiation therapy system. For each Program to be undertaken by PEKO pursuant to this Agreement, the parties will prepare a “Work Statement” and agree to said “Work Statement” in substantially the form attached as Attachment 1. Each Work Statement will describe: (i) the (i) services that PEKO will be responsible for providing to ViewRay and the deliverables that PEKO will be responsible for delivering to ViewRay (“Deliverable(s)”), (ii) delivery schedule for the Deliverables, (iii) pricing terms, (iv) work plan for the Program, and (v) ViewRay’s responsibilities in connection with the Program. Each Work Statement will be prepared based upon the requirements and information provided to PEKO by ViewRay. A separate Work Statement will be required for each Program; and each Work Statement will become subject to this Agreement only when mutually agreed and signed by ViewRay and PEKO.

  • Commercialization Reports Throughout the term of this Agreement and during the Sell-Off Period, and within thirty (30) days of December 31st of each year, Company will deliver to University written reports of Company’s and Sublicensees’ efforts and plans to develop and commercialize the innovations covered by the Licensed Rights and to make and sell Licensed Products. Company will have no obligation to prepare commercialization reports in years where (a) Company delivers to University a written Sales Report with active sales, and (b) Company has fulfilled all Performance Milestones. In relation to each of the Performance Milestones each commercialization report will include sufficient information to demonstrate achievement of those Performance Milestones and will set out timeframes and plans for achieving those Performance Milestones which have not yet been met.

  • Development Plan document specifying the work program, schedule, and relevant investments required for the Development and the Production of a Discovery or set of Discoveries of Oil and Gas in the Contract Area, including its abandonment.

  • Research Plan The Parties recognize that the Research Plan describes the collaborative research and development activities they will undertake and that interim research goals set forth in the Research Plan are good faith guidelines. Should events occur that require modification of these goals, then by mutual agreement the Parties can modify them through an amendment, according to Paragraph 13.6.

  • Quality Agreement Concurrently with execution of this Agreement, the Parties will enter into an agreement that details the quality assurance obligations of each Party with respect to the Manufacture and supply of Supplied Products under this Agreement (the “Quality Agreement”). Each Party shall perform its obligations under the Quality Agreement in accordance with the terms and conditions thereof. In the event of a conflict between the terms of the Quality Agreement and the terms of this Agreement, the provisions of the Quality Agreement shall govern.

  • Supply of Materials The following materials will be supplied by the department Name of Materials Rate. Place of delivery 1.

  • Commercialization Plan On a Product by Product basis, not later than sixty (60) days after the filing of the first application for Regulatory Approval of a Product in the Copromotion Territory, the MSC shall prepare and approve a rolling multiyear (not less than three (3) years) plan for Commercializing such Product in the Copromotion Territory (the "Copromotion Territory Commercialization Plan"), which plan includes a comprehensive market development, marketing, sales, supply and distribution strategy for such Product in the Copromotion Territory. The Copromotion Territory Commercialization Plan shall be updated by the MSC at least once each calendar year such that it addresses no less than the three (3) upcoming years. Not later than thirty (30) days after the filing of the first application for Regulatory Approval of a Product in the Copromotion Territory and thereafter on or before September 30 of each calendar year, the MSC shall prepare an annual commercialization plan and budget (the "Annual Commercialization Plan and Budget"), which plan is based on the then current Copromotion Territory Commercialization Plan and includes a comprehensive market development, marketing, sales, supply and distribution strategy, including an overall budget for anticipated marketing, promotion and sales efforts in the upcoming calendar year (the first such Annual Development Plan and Budget shall cover the remainder of the calendar year in which such Product is anticipated to be approved plus the first full calendar year thereafter). The Annual Commercialization Plan and Budget will specify which Target Markets and distribution channels each Party shall devote its respective Promotion efforts towards, the personnel and other resources to be devoted by each Party to such efforts, the number and positioning of Details to be performed by each Party, as well as market and sales forecasts and related operating expenses, for the Product in each country of the Copromotion Territory, and budgets for projected Pre-Marketing Expenses, Sales and Marketing Expenses and Post-Approval Research and Regulatory Expenses. In preparing and updating the Copromotion Territory Commercialization Plan and each Annual Commercialization Plan and Budget, the MSC will take into consideration factors such as market conditions, regulatory issues and competition.

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • Development and Commercialization Subject to Sections 4.6 and 4.7, Fibrocell shall be solely responsible for the development and Commercialization of Fibrocell Products and Improved Products. Fibrocell shall be responsible for all costs incurred in connection with the Fibroblast Program except that Intrexon shall be responsible for the following: (a) costs of establishing manufacturing capabilities and facilities in connection with Intrexon’s manufacturing obligation under Section 4.6 (provided, however, that Intrexon may include an allocable portion of such costs, through depreciation and amortization, when calculating the Fully Loaded Cost of manufacturing a Fibrocell Product, to the extent such allocation, depreciation, and amortization is permitted by US GAAP, it being recognized that the majority of non-facilities scale-up costs cannot be capitalized and amortized under US GAAP); (b) costs of basic research with respect to the Intrexon Channel Technology and Intrexon Materials (i.e., platform improvements) but, for clarity, excluding research described in Section 4.7 or research requested by the JSC for the development of a Fibrocell Product or an Improved Product (which research costs shall be reimbursed by Fibrocell); (c) [*****]; and (d) costs of filing, prosecution and maintenance of Intrexon Patents. The costs encompassed within subsection (a) above shall include the scale-up of Intrexon Materials and related active pharmaceutical ingredients for clinical trials and Commercialization of Fibrocell Products undertaken pursuant to Section 4.6, which shall be at Intrexon’s cost whether it elects to conduct such efforts internally or through Third Party contractors retained by either Intrexon or Fibrocell (with Intrexon’s consent).

  • Manufacturing Technology Transfer With respect to each Technology Transfer Product, upon AbbVie’s written request after the Inclusion Date for the Included Target to which such Technology Transfer Product is Directed, Morphic shall effect a full transfer to AbbVie or its designee (which designee may be an Affiliate or a Third Party manufacturer) of all Morphic Know-How and Joint Know-How relating to the then-current process for the Manufacture of such Technology Transfer Product (the “Manufacturing Process”) and to implement the Manufacturing Process at facilities designated by AbbVie (such transfer and implementation, as more fully described in this Section 5.3, the “Manufacturing Technology Transfer”). To assist with the Manufacturing Technology Transfer, Morphic will make its personnel reasonably available to AbbVie during normal business hours for up to [***] FTE hours with respect to each Included Target (in each case, free of charge to AbbVie) to transfer and implement the Manufacturing Process under this Section 5.3. Thereafter, if requested by AbbVie, Morphic shall continue to perform such obligations; provided, that AbbVie will reimburse Morphic for its full-time equivalent (FTE) costs (for clarity, in excess of [***] FTE hours) and any reasonable and verifiable out-of-pocket costs incurred in providing such assistance. CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED.

Time is Money Join Law Insider Premium to draft better contracts faster.